PSNL vs. AHCO, VRDN, CDNA, AVAH, PNTG, GRAL, FLGT, CSTL, AUNA, and FTRE
Should you be buying Personalis stock or one of its competitors? The main competitors of Personalis include AdaptHealth (AHCO), Viridian Therapeutics (VRDN), CareDx (CDNA), Aveanna Healthcare (AVAH), The Pennant Group (PNTG), Grail (GRAL), Fulgent Genetics (FLGT), Castle Biosciences (CSTL), Auna (AUNA), and Fortrea (FTRE). These companies are all part of the "healthcare" industry.
Personalis vs.
AdaptHealth (NASDAQ:AHCO) and Personalis (NASDAQ:PSNL) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, institutional ownership, earnings, analyst recommendations, dividends, community ranking, profitability and media sentiment.
In the previous week, AdaptHealth had 1 more articles in the media than Personalis. MarketBeat recorded 5 mentions for AdaptHealth and 4 mentions for Personalis. Personalis' average media sentiment score of 0.92 beat AdaptHealth's score of 0.77 indicating that Personalis is being referred to more favorably in the news media.
Personalis has lower revenue, but higher earnings than AdaptHealth. Personalis is trading at a lower price-to-earnings ratio than AdaptHealth, indicating that it is currently the more affordable of the two stocks.
AdaptHealth presently has a consensus price target of $13.80, suggesting a potential upside of 71.86%. Personalis has a consensus price target of $7.80, suggesting a potential upside of 103.66%. Given Personalis' higher probable upside, analysts plainly believe Personalis is more favorable than AdaptHealth.
AdaptHealth has a beta of 1.44, suggesting that its share price is 44% more volatile than the S&P 500. Comparatively, Personalis has a beta of 1.89, suggesting that its share price is 89% more volatile than the S&P 500.
Personalis received 37 more outperform votes than AdaptHealth when rated by MarketBeat users. Likewise, 68.31% of users gave Personalis an outperform vote while only 62.41% of users gave AdaptHealth an outperform vote.
AdaptHealth has a net margin of -6.57% compared to Personalis' net margin of -104.52%. AdaptHealth's return on equity of 9.62% beat Personalis' return on equity.
82.7% of AdaptHealth shares are held by institutional investors. Comparatively, 61.9% of Personalis shares are held by institutional investors. 4.4% of AdaptHealth shares are held by insiders. Comparatively, 3.8% of Personalis shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Summary
AdaptHealth and Personalis tied by winning 8 of the 16 factors compared between the two stocks.
Get Personalis News Delivered to You Automatically
Sign up to receive the latest news and ratings for PSNL and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Personalis Competitors List
Related Companies and Tools
This page (NASDAQ:PSNL) was last updated on 4/25/2025 by MarketBeat.com Staff
